A Pharmacokinetic and Drug Interaction Study of JNJ-26489112 in Healthy Volunteers
Status:
Completed
Trial end date:
2010-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effect of 26489112 on the pharmacokinetics
(blood levels) of a combination of 3 drugs administered to healthy volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.